Under the venture, called SharedClarity, the member organizations will conduct independent studies on the long-term effectiveness of medical devices implanted in patients, such as stents, defibrillators, pacemakers, knee and hip implants and heart valves.
Click here to read the full story on the joint venture in Becker’s Hospital Review.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
